191 related articles for article (PubMed ID: 174057)
1. Pediatric familial type II hyperlipoproteinemia: therapy with diet and colestipol resin.
Glueck CJ; Fallat RW; Mellies M; Tsang RC
Pediatrics; 1976 Jan; 57(1):68-74. PubMed ID: 174057
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of long-term diet and diet plus bile acid-binding resin cholesterol-lowering therapy in 73 children heterozygous for familial hypercholesterolemia.
Glueck CJ; Mellies MJ; Dine M; Perry T; Laskarzewski P
Pediatrics; 1986 Aug; 78(2):338-48. PubMed ID: 3526270
[TBL] [Abstract][Full Text] [Related]
3. Colestipol, clofibrate, cholestyramine and combination therapy in the treatment of familial hyperbetalipoproteinaemia.
Stein EA; Heimann KW
S Afr Med J; 1975 Jul; 49(31):1252-6. PubMed ID: 168650
[TBL] [Abstract][Full Text] [Related]
4. The effects of colestipol on the metabolism of very-low-density lipoproteins in man.
Witztum JL; Schonfeld G; Weidman SW
J Lab Clin Med; 1976 Dec; 88(6):1008-18. PubMed ID: 186544
[TBL] [Abstract][Full Text] [Related]
5. Normalization of low-density-lipoprotein levels in heterozygous familial hypercholesterolemia with a combined drug regimen.
Kane JP; Malloy MJ; Tun P; Phillips NR; Freedman DD; Williams ML; Rowe JS; Havel RJ
N Engl J Med; 1981 Jan; 304(5):251-8. PubMed ID: 7003391
[TBL] [Abstract][Full Text] [Related]
6. Therapy of familial hypercholesterolemia in childhood: diet and cholestyramine resin for 24 to 36 months.
Glueck CJ; Tsang RC; Fallat RW; Mellies M
Pediatrics; 1977 Mar; 59(3):433-41. PubMed ID: 840563
[TBL] [Abstract][Full Text] [Related]
7. [Long term treatment of familial hypercholesterolemia with Colestipol, a new anionic exchange resin (author's transl)].
Briani G; Fellin R; Balestrieri P; Baggio G; Baiocchi MR; Crepaldi G
G Ital Cardiol; 1975; 5(3):390-404. PubMed ID: 1149965
[TBL] [Abstract][Full Text] [Related]
8. [A comparative study of colestipol and colestyramine in children and adolescents with familial hypercholesterolaemia (author's transl)].
Mordasini R; Twelsick F; Oster P; Schellenberg B; Raetzer H; Heuck CC; Schlierf G
Monatsschr Kinderheilkd (1902); 1978 Jul; 126(7):436-40. PubMed ID: 672910
[TBL] [Abstract][Full Text] [Related]
9. Comparative efficacy of colestipol and clofibrate in type IIa hyperlipoproteinemia.
Vecchio TJ; Linden CV; O'Connell MJ; Heilman J
Arch Intern Med; 1982 Apr; 142(4):721-3. PubMed ID: 7073415
[TBL] [Abstract][Full Text] [Related]
10. Results of colestipol therapy in Type II hyperlipoproteinemia.
Lees AM; McCluskey MA; Lees RS
Atherosclerosis; 1976; 24(1-2):129-40. PubMed ID: 182181
[TBL] [Abstract][Full Text] [Related]
11. Clofibrate-induced low density liporotein elevation. Therapeutic implications and treatment by colestipol resin.
Rose HG; Haft GK; Juliano J
Atherosclerosis; 1976; 23(3):413-27. PubMed ID: 178325
[TBL] [Abstract][Full Text] [Related]
12. Colestipol in familial type II hyperlipoproteinemia: a three-year trial.
Harvengt C; Desager JP
Clin Pharmacol Ther; 1976 Sep; 20(3):310-4. PubMed ID: 182429
[TBL] [Abstract][Full Text] [Related]
13. Use of combined diet and colestipol in long-term (7--7 1/2 years) treatment of patients with type II hyperlipoproteinemia.
Kuo PT; Hayase K; Kostis JB; Moreyra AE
Circulation; 1979 Feb; 59(2):199-211. PubMed ID: 215338
[TBL] [Abstract][Full Text] [Related]
14. Treatment of familial hypercholesterolemia with drugs in children.
Stein EA
Arteriosclerosis; 1989; 9(1 Suppl):I145-51. PubMed ID: 2912428
[TBL] [Abstract][Full Text] [Related]
15. Probucol further lowers the serum cholesterol of colestipol-treated patients with hypercholesterolemia.
Schonfeld G; Witztum J; Basich P
Artery; 1982; 10(2):99-104. PubMed ID: 7092583
[TBL] [Abstract][Full Text] [Related]
16. The effects of colestipol resin and of colestipol plus clofibrate on the turnover of plasma cholesterol in man.
Goodman DS; Noble RP; Dell RB
J Clin Invest; 1973 Oct; 52(10):2646-55. PubMed ID: 4729058
[TBL] [Abstract][Full Text] [Related]
17. Effects of combined therapy with lovastatin and colestipol in heterozygous familial hypercholesterolemia. Effects on kinetics of apolipoprotein B.
Vega GL; East C; Grundy SM
Arteriosclerosis; 1989; 9(1 Suppl):I135-44. PubMed ID: 2912427
[TBL] [Abstract][Full Text] [Related]
18. Intensive combination drug therapy of familial hypercholesterolemia with lovastatin, probucol, and colestipol hydrochloride.
Witztum JL; Simmons D; Steinberg D; Beltz WF; Weinreb R; Young SG; Lester P; Kelly N; Juliano J
Circulation; 1989 Jan; 79(1):16-28. PubMed ID: 2642754
[TBL] [Abstract][Full Text] [Related]
19. Fat-soluble vitamin concentrations in hypercholesterolemic children treated with colestipol.
Schwarz KB; Goldstein PD; Witztum JL; Schonfeld G
Pediatrics; 1980 Feb; 65(2):243-50. PubMed ID: 7354970
[TBL] [Abstract][Full Text] [Related]
20. Diet and probucol in lowering cholesterol concentrations. Additive effects on plasma cholesterol concentrations in patients with familial type ii hyperlipoproteinemia.
LeLorier J; DuBreuil-Quidoz S; Lussier-Cacan S; Huang YS; Davignon J
Arch Intern Med; 1977 Oct; 137(10):1429-34. PubMed ID: 335998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
